Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9141 |
High Similarity |
NPD4908 |
Phase 1 |
0.907 |
High Similarity |
NPD4625 |
Phase 3 |
0.9 |
High Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8898 |
High Similarity |
NPD4749 |
Approved |
0.874 |
High Similarity |
NPD1610 |
Phase 2 |
0.8571 |
High Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.8425 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8421 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8406 |
Intermediate Similarity |
NPD6100 |
Approved |
0.8406 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8346 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8271 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.8209 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.8175 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8175 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8045 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.8042 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7985 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7972 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7956 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7945 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7917 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7914 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7907 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7899 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7801 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7793 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7755 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7755 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7737 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.773 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7712 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.771 |
Intermediate Similarity |
NPD7340 |
Approved |
0.7703 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7671 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7647 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7643 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7612 |
Intermediate Similarity |
NPD4626 |
Approved |
0.761 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7603 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7584 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7581 |
Intermediate Similarity |
NPD846 |
Approved |
0.7581 |
Intermediate Similarity |
NPD940 |
Approved |
0.758 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7571 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7569 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7559 |
Intermediate Similarity |
NPD2342 |
Discontinued |
0.7554 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7552 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7548 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7538 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7538 |
Intermediate Similarity |
NPD7635 |
Approved |
0.7536 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7535 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7534 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7534 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7518 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7518 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7518 |
Intermediate Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7517 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD1611 |
Approved |
0.75 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7484 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7483 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7482 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7481 |
Intermediate Similarity |
NPD1398 |
Phase 1 |
0.7481 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7468 |
Intermediate Similarity |
NPD37 |
Approved |
0.7466 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7466 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7466 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7466 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7464 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7452 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7445 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7436 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7436 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7436 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7431 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7419 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7419 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7415 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7407 |
Intermediate Similarity |
NPD5691 |
Approved |
0.74 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7394 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7391 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7389 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7386 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7355 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7343 |
Intermediate Similarity |
NPD7265 |
Discontinued |
0.7343 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7338 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7333 |
Intermediate Similarity |
NPD6815 |
Approved |
0.7329 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7325 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7319 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7308 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7308 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7308 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7303 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7292 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7292 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7292 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.729 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.729 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7258 |
Intermediate Similarity |
NPD288 |
Approved |
0.7248 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7246 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7241 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7239 |
Intermediate Similarity |
NPD709 |
Approved |
0.7239 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7237 |
Intermediate Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7237 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7237 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7231 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7226 |
Intermediate Similarity |
NPD17 |
Approved |
0.7226 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7226 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7226 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7214 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7211 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD968 |
Approved |
0.7206 |
Intermediate Similarity |
NPD3091 |
Approved |
0.72 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7194 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7194 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7194 |
Intermediate Similarity |
NPD2232 |
Approved |
0.719 |
Intermediate Similarity |
NPD6090 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD6746 |
Phase 2 |
0.7177 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7177 |
Intermediate Similarity |
NPD844 |
Approved |
0.7177 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7171 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD7837 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7163 |
Intermediate Similarity |
NPD4339 |
Clinical (unspecified phase) |
0.7163 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7153 |
Intermediate Similarity |
NPD3444 |
Approved |
0.7153 |
Intermediate Similarity |
NPD6830 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7153 |
Intermediate Similarity |
NPD3445 |
Approved |
0.7153 |
Intermediate Similarity |
NPD3443 |
Approved |
0.7122 |
Intermediate Similarity |
NPD3092 |
Approved |
0.7122 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7122 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7117 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7114 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7105 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7105 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7101 |
Intermediate Similarity |
NPD4059 |
Approved |
0.7101 |
Intermediate Similarity |
NPD2286 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD3019 |
Approved |
0.7097 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7097 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7095 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7095 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD7046 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD5929 |
Approved |
0.7089 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7086 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.708 |
Intermediate Similarity |
NPD6580 |
Approved |
0.708 |
Intermediate Similarity |
NPD6581 |
Approved |
0.7078 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD2157 |
Approved |
0.7075 |
Intermediate Similarity |
NPD4579 |
Clinical (unspecified phase) |
0.7068 |
Intermediate Similarity |
NPD228 |
Approved |
0.7066 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD1712 |
Approved |
0.7063 |
Intermediate Similarity |
NPD5736 |
Approved |
0.7055 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7055
|
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |